Navigation Links
NovaBay Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results
Date:4/1/2009

2008 and Recent Events Highlighted

EMERYVILLE, Calif., April 1, /PRNewswire-FirstCall/ -- NovaBay Pharmaceuticals, Inc. (NYSE Amex: NBY), a mid-stage biopharmaceutical company developing first-in-class anti-infective products for the treatment and prevention of a wide range of infections without causing resistance, reported today its financial results for the fourth quarter and full year ended December 31, 2008. The company also announced clinical development progress and operational highlights during the year 2008.

License and collaboration revenue for the fourth quarter of 2008 increased 44% to $2.2 million from $1.5 million for the fourth quarter of 2007. The net loss for the fourth quarter of 2008 was $(1.5) million, or $(0.07) per share, compared to a net loss of $(1.4) million, or $(0.09) per share, reported for the fourth quarter of 2007. License and collaboration revenue for the year ended December 31, 2008 increased 14% to $6.7 million, from $5.9 million for the year ended December 31, 2007. The net loss for the year ended December 31, 2008 was $8.1 million, or $(0.38) per share, compared to a net loss of $5.4 million, or $(0.60) per share reported for the year ended December 31, 2007. As of December 31, 2008, the company's cash and cash equivalents totaled $12.1 million.

"During 2008, NovaBay continued to advance development of our Aganocide(R) compounds, our proprietary, first-in-class anti-infective products that are designed to mimic the human body's natural defense against infection without developing resistance," said Dr. Ron Najafi, chairman and chief executive officer of NovaBay. "We have built on this solid progress in 2009, as evidenced by our recently announced exclusive agreement with Galderma to develop and commercialize our Aganocides for major dermatological conditions. This is NovaBay
'/>"/>

SOURCE NovaBay Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBays Novel Aganocide Drugs for Major Dermatological Conditions
2. NovaBay Pharmaceuticals Prices Initial Public Offering of Common Stock
3. Alseres Pharmaceuticals, Inc. Complies with NASDAQ Rule Regarding Recently Filed 10-K
4. Angiotech Pharmaceuticals, Inc. announces License Agreement with Baxter International Inc.
5. Trubion Pharmaceuticals, Inc. Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Systemic Lupus Erythematosus (SLE)
6. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results
7. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2008 Financial Results
8. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2008 Financial Results on Friday, March 13, 2009 at 8:30am EDT
9. Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008
10. Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities
11. Alseres Pharmaceuticals, Inc. Announces $1 Million Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2012)... 21, 2012   Cord Blood America, Inc . ... ), the umbilical cord blood stem cell preservation ... of stem cells to families nationwide and internationally, today ... increased by 6.7%  to $1.55 million compared to $1.45 ... a gross profit of $1.12 million in the first ...
(Date:5/21/2012)... CITY, Panama, May 21, 2012 ... 16 May 2012 to discuss the potential use of ... a tool to combat Dengue Fever in Panama. ... Tropical Research Institute (STRI), The Gorgas Memorial Institute for ... together national and regional experts from these institutes as ...
(Date:5/18/2012)... HACKENSACK, N.J., May 18, 2012 Champions ... has received U.S. Clinical Laboratory Improvement Amendment (CLIA) ... Mental Hygiene Office of Health Care Quality required ... The Company,s President, Ronnie Morris, ... milestone for our Company. This approval validates the ...
(Date:5/17/2012)... 17, 2012 The " ... Study " analyzes and studies the U.S. market for ... anesthesia drugs in U.S., potential buyers, export & import system for ... Browse market data tables and in-depth TOC of ... 2015) -   U.S. Market Entry ...
Breaking Biology Technology:Cord Blood America Announces First Quarter Financial Results 2Cord Blood America Announces First Quarter Financial Results 3Expert Meeting Discusses Testing of Oxitec Transgenic Mosquitoes in Panama 2Expert Meeting Discusses Testing of Oxitec Transgenic Mosquitoes in Panama 3Champions Oncology Inc. Receives Approval from U.S. Regulatory Authorities 2Champions Oncology Inc. Receives Approval from U.S. Regulatory Authorities 3Anesthesia Drugs Market in U.S. worth $7 Billion by 2015: MarketsandMarkets 2Anesthesia Drugs Market in U.S. worth $7 Billion by 2015: MarketsandMarkets 3
... of Madison is asking for bids on the construction of downtown ... would be able to charge user fees and would take on ... county and state for the right to operate. The project would ... said plans and costs are still not finalized. , ,Now, though, ...
... Madison, Wis. While the Madison chapter ... looking ahead for new social and technological developments, Scott Converse ... important if they want to see where the next big ... at the UW-Madison School of Business and founder of the ...
... anticipation of what may await them on Christmas morning. For me, ... companies vying for a place at February's DEMO@15 show. ... 70 or so companies that will debut at the show, there ... until the conference gems we can unwrap now. , ,One ...
Other Biology Technology:Madison asks for wireless bids; airport, downtown would be first 2Business-school IT director points to reasons for wireless trend 2An early Christmas gift 2
(Date:5/21/2012)... 2012 Researchers from Seattle Biomedical Research Institute (Seattle ... Edinburgh have uncovered new knowledge related to host-parasite interaction ... to bind to cells in the brain and cause ... disease. Three related papers will be published in the ... the National Academy of Sciences ), a premier scientific ...
(Date:5/21/2012)... 21, 2012  Chiltern International Limited (Chiltern), a ... has been recognized with a CRO Leadership Award ... and Regulatory. The awards are given by Life ... of Nice Insight. Glenn ... to be recognized as a CRO leader in ...
(Date:5/21/2012)... combination of cues in their hunting sequence - capture, handling ... and consume and which ones they are better off leaving ... listen to their prey, then they assess its size, and ... and her team from the Smithsonian Tropical Research Institute in ... The Science of Nature . , To survive, predators must ...
Breaking Biology News(10 mins):New discoveries about severe malaria 2Chiltern Wins CRO Leadership Award From Life Science Leader 2What sounds good doesn't always taste good 2Depression associated with sustained brain signals 12686 1Depression associated with sustained brain signals 12686 2Breast cancer patients with BRCA mutations 4 times more likely to get cancer in opposite breast 70037 1Breast cancer patients with BRCA mutations 4 times more likely to get cancer in opposite breast 70037 2Breast cancer patients with BRCA mutations 4 times more likely to get cancer in opposite breast 70037 3Breast cancer patients with BRCA mutations 4 times more likely to get cancer in opposite breast 70037 4Childhood Cancer Survivors At Higher Odds of Early Death 70034 1Childhood Cancer Survivors At Higher Odds of Early Death 70034 2
... In one of the first national studies on ... hospitals, researchers from the Indiana University School of ... Roudebush Veterans Administration Medical Center report that hospitals ... have lower rates of antibiotic resistance. , ...
... contracting a serious bacterial infection is that the victim ... destructive inflammation throughout the body, often leading to heart ... hospital intensive care units may be helpless to save ... study by Emory University and the Centers for Disease ...
... from HIV infection can lead to trouble when it ... appearing in the Oct. 1 issue of The Journal ... demonstrates that HIV-1 infected patients with suppressed immunity represent, ... group for malaria," says Jean-Pierre Van geertruyden, MD, MSc, ...
Other Biology News:Controlling antibiotics and antibiotic resistance in hospitals 2Researchers identify new weapon to fight deadly bacterial sepsis 2Researchers identify new weapon to fight deadly bacterial sepsis 3Malaria treatment efficacy compromised in certain HIV-positive patients 2
... Thermo Labsystems' Wellwash AC is ... microplate washer available, and is ... for wash, waste and rinse ... and automatic rinsing and priming ...
... Rabbit polyclonal to MLF1 Interacting Protein/PBIP1 ... all tested applications). ... to amino acids 73-83 of Human ... Entrez Gene ID: 359815 ...
... save space and organize gloves, safety ... They are the perfect benchtop storage ... labs, processing and manufacturing. Clear static-dissipative ... particles they attract. Many other sizes ...
... These handy dispensers save space ... wipers, hats, and other garb. ... storage bins for small parts ... manufacturing. Clear acrylic. Many other ...
Biology Products: